What does D&D Pharmatech do?

D&D Pharmatech (347850.KQ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 347850.KQ's market cap?

D&D Pharmatech (347850.KQ) has a market capitalization of approximately $2.58 trillion, as of July 22, 2026, based on the most recent share price and shares outstanding.

Does 347850.KQ pay a dividend?

No — D&D Pharmatech (347850.KQ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

347850.KQ

D&D Pharmatech

KOE·Biotechnology · Healthcare

₩59,000₩2,000−3.28%

Market cap₩2.58T·Jul 22 6:30 AM UTC

Price Chart

₩59,000−₩2,000.00 (−3.28%)today

+615.15%CAGR +141.76%

Select date range

FromTo

Apr 29, 2024Apr 29, 2024 → Jul 22, 2026· 2.2 yrsJul 22, 2026

Key Metrics

347850.KQ does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue₩3.01B

Net Income−₩23.20B

Net Margin−770.0%

Operating Cash Flow−₩24.90B

Capital Expenditures₩36.59M

Free Cash Flow−₩24.94B

Return on Equity−31.1%

Return on Invested Capital−12.0%

Net Cash₩18.58B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 347850.KQ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 347850.KQ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 347850.KQ and 80,000+ other tickers.

About D&D Pharmatech

Established in 2014 and headquartered in Seongnam-si, South Korea, D&D Pharmatech Inc. is a clinical-stage biotechnology firm dedicated to discovering and advancing pharmaceutical treatments in both South Korea and the United States. The company's robust drug pipeline includes several candidates currently in clinical development: Phase II Trials: NLY01-PD, NLY01-AD, and NLY01-D are being investigated for their efficacy against Parkinson's disease, Alzheimer's disease, and type 2 diabetes, respectively. Completed Phase IIa Trial: P4M01 has successfully finished its Phase IIa study for the…

CEO: Seul-ki Lee
Sector: Healthcare
Industry: Biotechnology
Exchange: KOE
Employees: 22
Website: www.ddpharmatech.com

Peers

Peers Tab

226950.KQ

OliX Pharmaceuticals,Inc

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 347850.KQ

What does D&D Pharmatech do?: D&D Pharmatech (347850.KQ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 347850.KQ's market cap?: D&D Pharmatech (347850.KQ) has a market capitalization of approximately $2.58 trillion, as of July 22, 2026, based on the most recent share price and shares outstanding.
Does 347850.KQ pay a dividend?: No — D&D Pharmatech (347850.KQ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.